|
|
|
Insider
Information: |
Lange Louis G |
Relationship: |
|
City: |
Palo Alto |
State: |
CA |
|
|
Insider
Summary: |
|
|
|
Companies Owned : |
5 |
|
Direct
Shares |
582,756 |
|
Indirect Shares
|
228,940 |
|
|
Direct
Value |
$89,007 |
|
|
Indirect Value
|
$466,579 |
|
|
Total
Shares |
811,696 |
|
|
Total
Value |
$555,586 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
Total
Filings :
|
0
|
0
|
Stock
price went up :
|
0
|
0
|
Stock
price went down : |
0
|
0
|
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
Percentage
Gain/Loss : |
0.0%
|
0.0%
|
|
|
|
|
|
|
Holdings
:
Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold |
|
CV Therapeutics Inc |
CVTX |
Chairman & CEO, Director |
2009-04-09 |
483,618 |
2009-04-09 |
6,359 |
Premium* |
|
Maxygen Inc |
MAXY |
Director |
2012-06-06 |
60,000 |
2009-09-22 |
0 |
Premium* |
|
Esperion Therapeutics, Inc. |
ESPR |
Director |
2013-07-01 |
17,814 |
2013-07-01 |
197,703 |
Premium* |
|
Cymabay Therapeutics, Inc. |
CBAY |
Director |
2013-10-11 |
1,446 |
|
0 |
Premium* |
|
Newamsterdam Pharma Ord Shs |
NAMS |
|
2023-12-29 |
19,878 |
2024-02-13 |
24,878 |
Premium* |
|
|
|
|
|
|
|
|
|
|
Records found :
68 |
Free Registration Required For Full Results. Limit: 25
|
|
Download |
Page 4 of 3
|
68 Records found
|
|
Page 4 of 3 |
|
Free Registration Required For Full Results. Limit: 25
|
|
|
Transaction Code Key: |
Ownership Code Key |
|
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
|
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
|
IO |
- Initital Ownership |
D |
- Disposed |
|
|
|
|
|
|